HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis - PubMed (original) (raw)

HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis

Y Chen et al. Mol Cell Biol. 1997 Oct.

Abstract

The protein encoded by the human gene HEC (highly expressed in cancer) contains 642 amino acids and a long series of leucine heptad repeats at its C-terminal region. HEC protein is expressed most abundantly in the S and M phases of rapidly dividing cells but not in terminal differentiated cells. It localizes to the nuclei of interphase cells, and a portion distributes to centromeres during M phase. Inactivation of HEC by microinjection of specific monoclonal antibodies into cells during interphase severely disturbs the subsequent mitoses. Disordered sister chromatid alignment and separation, as well as the formation of nonviable cells with multiple, fragmented micronuclei, are common features observed. These results suggest that the HEC protein may play an important role in chromosome segregation during M phase.

PubMed Disclaimer

Cited by

Centromeres in cancer: Unraveling the link between chromosomal instability and tumorigenesis.
Karami Fath M, Nazari A, Parsania N, Behboodi P, Ketabi SS, Razmjouei P, Farzam F, Shafagh SG, Nabi Afjadi M. Karami Fath M, et al. Med Oncol. 2024 Oct 1;41(11):254. doi: 10.1007/s12032-024-02524-0. Med Oncol. 2024. PMID: 39352464 Review.
Coregulation of NDC80 Complex Subunits Determines the Fidelity of the Spindle-Assembly Checkpoint and Mitosis.
Kim S, Lau TTY, Liao MK, Ma HT, Poon RYC. Kim S, et al. Mol Cancer Res. 2024 May 2;22(5):423-439. doi: 10.1158/1541-7786.MCR-23-0828. Mol Cancer Res. 2024. PMID: 38324016 Free PMC article.
Screening of four signature genes for clinical testing through bioinformatics and in vitro methods in head and neck squamous cell carcinoma.
Javed M, Bukhari RS, Rasool R, Alhomrani M, Alghamdi SA, Habeeballah H, Ramzan F, Baothman BK, Kashif M, Almaghrabi S, Izmirly AM, Khalid SY. Javed M, et al. Am J Cancer Res. 2023 May 15;13(5):1826-1844. eCollection 2023. Am J Cancer Res. 2023. PMID: 37293145 Free PMC article.
Stable kinetochore-microtubule attachment requires loop-dependent Ndc80-Ndc80 binding.
Polley S, Müschenborn H, Terbeck M, De Antoni A, Vetter IR, Dogterom M, Musacchio A, Volkov VA, Huis In 't Veld PJ. Polley S, et al. EMBO J. 2023 Jul 3;42(13):e112504. doi: 10.15252/embj.2022112504. Epub 2023 May 19. EMBO J. 2023. PMID: 37203876 Free PMC article.
NDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma.
Hu C, Lin W, Zhao K, Tian G, Kong X, Luo G, Wolf DA, Cheng Y. Hu C, et al. iScience. 2023 Apr 3;26(4):106531. doi: 10.1016/j.isci.2023.106531. eCollection 2023 Apr 21. iScience. 2023. PMID: 37123230 Free PMC article.

References

1. J Cell Biol. 1990 Oct;111(4):1491-504 - PubMed
1. Cell. 1989 Sep 22;58(6):1193-8 - PubMed
1. Nature. 1991 Jan 10;349(6305):132-8 - PubMed
1. Trends Biochem Sci. 1991 May;16(5):173-7 - PubMed
1. Cell. 1991 Oct 18;67(2):293-302 - PubMed

HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis - PubMed (original) (raw)